# Oral Propanolol for Surgically Inaccessible Cavernous Malformations

> **NCT03523650** · PHASE1 · UNKNOWN · sponsor: **University of Virginia** · enrollment: 346 (estimated)

## Conditions studied

- Cavernous Malformations,Cerebral and/or Spinal

## Interventions

- **DRUG:** Propranolol Oral Tablet
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03523650
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-07
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 346 (ESTIMATED)
- **Last updated:** 2018-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03523650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03523650, "Oral Propanolol for Surgically Inaccessible Cavernous Malformations". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03523650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*